Phase IV
From DrugPedia: A Wikipedia for Drug discovery
(Difference between revisions)
(New page: '''Phase IV ( Post-marketing surveillance)''' The objectives of post-marketing surveillance are to identify rare adverse reactions not detected during pre-licensure studies, monitor increa...) |
|||
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
'''Phase IV ( Post-marketing surveillance)''' | '''Phase IV ( Post-marketing surveillance)''' | ||
| - | The objectives of post-marketing surveillance | + | |
| + | The objectives of post-marketing surveillance is to | ||
| + | #Understand the side effect of drug that is associated with long term uses. | ||
| + | # Extending use of drug to different class of patient such as children. | ||
| + | #Finding new therapeutic opportunities or new formulations that may increase the effectiveness of the drug and allow it to be administered to a larger number of patients. | ||
Current revision
Phase IV ( Post-marketing surveillance)
The objectives of post-marketing surveillance is to
- Understand the side effect of drug that is associated with long term uses.
- Extending use of drug to different class of patient such as children.
- Finding new therapeutic opportunities or new formulations that may increase the effectiveness of the drug and allow it to be administered to a larger number of patients.
